Astec LifeSciences has appointed Burjis Godrej as the company’s Managing Director for a five-year term, effective from April 1, 2025, to March 31, 2030. He will serve in this capacity without any remuneration.
Current Role and Responsibilities
Burjis Godrej currently serves as the Head of Special Projects at Godrej Agrovet Limited (GAVL). In this role, he oversees agrochemical projects for both Astec LifeSciences Limited and the Crop Protection businesses of GAVL. His responsibilities include evaluating products, exploring synergies, assessing technologies, analyzing business models and geographies, engaging consultants, and planning capital expenditures.
Executive and Non-Executive Positions
As per the Godrejastec , since November 1, 2022, Burjis Godrej has held the position of Executive Director at GAVL. Additionally, he serves as a Non-Executive Director at Astec LifeSciences Limited and Godrej Maxximilk Private Limited, both subsidiaries of GAVL.
Educational Background and Career Path
Burjis Godrej earned his MBA from Harvard Business School in 2021. He first joined GAVL in 2017 as part of the strategy division, where he worked on new product development. His role involved monitoring R&D activities, improving product quality, conducting new product trials, and fostering innovation partnerships with external organizations. Before his tenure at GAVL, he worked at Conservis Corporation, a company specializing in farm management software. Conservis has since become a joint venture between RaboBank and Tellus Corporation.
Strengthening Leadership at Astec LifeSciences
With his extensive experience in agrochemicals, strategic planning, and innovation, Burjis Godrej is expected to play a key role in driving growth and innovation at Astec LifeSciences.
